General Updates

Registered & Corporate Office: AMANTA HEALTHCARE LIMITED 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA. Tel.: 079 – 67777600 Email: info@amanta.co.in Website: www.amanta.co.in CIN: L24139GJ1994PLC023944 August 05, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. Scrip Code: 544502 Trading Symbol: AMANTA Dear Sir/Madam Sub: Statement of deviation or variation in utilization of funds, if any, under Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") Pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with related SEBI Circular, a statement of deviation or variation in utilisation of funds raised through 'IPO' for the quarter ended June 30, 2026, duly reviewed by the Audit Committee of the Company, is enclosed herewith. We hereby confirm that there has been no deviation or variation in the use of proceeds of funds raised through Public Issue. Hence, Statement is being submitted as per the prescribed format. You are requested to take the aforesaid information on your record. Thanking you, Yours sincerely, For AMANTA HEALTHCARE LIMITED NIKHITA DINODIA COMPANY SECRETARY & COMPLIANCE OFFICER Encl.: As above Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720 Registered & Corporate Office: AMANTA HEALTHCARE LIMITED 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA. Tel.: 079 – 67777600 Email: info@amanta.co.in Website: www.amanta.co.in CIN: L24139GJ1994PLC023944 Annexure A Statement of Deviation / Variation in utilisation of funds raised Name of listed entity Amanta Healthcare Limited Mode of Fund Raising Public Issue – Initial Public Offer Date of Raising Funds September 09, 2025 (Date of Listing) Amount Raised ₹126 crore Report filed for Quarter ended June 30, 2026 Monitoring Agency Applicable Monitoring Agency Name, if applicable CRISIL Ratings Limited Is there a Deviation / Variation in use of funds raised No If yes, whether the same is pursuant to change in terms of a contract or NA objects, which was approved by the shareholders If Yes, Date of shareholder Approval NA Explanation for the Deviation / Variation NA Comments of the Audit Committee after review No comments Comments of the auditors, if any No comments Objects for which funds have been raised and where there has been a deviation, in the following table: (Rs. In lakhs) Original Object Modified Original Modified Funds Amount of Remarks if any Object, if Allocation allocatio Utilised Deviation any n, if any /Variation for the quarter according to applicable object Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and - 7,000.00 - 6004.87 - - machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and - 3,013.11 - 745.88 - - machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat. During the quarter ended September 30, 2025, the issue General corporate purposes - 660.46 302.08 302.08 - expenses were modified to the extent of GST payment made Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720 Registered & Corporate Office: AMANTA HEALTHCARE LIMITED 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad–380058, Gujarat, INDIA. Tel.: 079 – 67777600 Email: info@amanta.co.in Website: www.amanta.co.in CIN: L24139GJ1994PLC023944 over the cost as per the Offer Document filed for the IPO as certified by Independent Chartered Accountant and affirmed by the monitoring agency. Consequent to this, general corporate purpose expenses was also modified and reduced to that extent. During the quarter ended September 30, 2025, the issue expenses were modified to the extent of GST payment made over the cost as per the Offer Document filed for Issue Expenses - 1,926.43 2,284.81 2,284.81 - the IPO as certified by Independent Chartered Accountant and affirmed by the monitoring agency. Consequent to this, general corporate purpose expenses was also modified and reduced to that extent. Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc. For, Amanta Healthcare Limited Paras Mehta Chief Financial Officer Factory: 876, N.H. No. 8, Hariyala, Kheda – 387411, Gujarat, India. Tel 2694287700 Fax 2694287720